Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline : a link between noradrenergic and glutamatergic function?

Potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function has been proposed as being useful in the treatment of depression, but thus far, little is known about the possible changes in AMPA receptor expression in the brain, after antidepressant treatment. The p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental brain research 2006-04, Vol.170 (4), p.448-456
Hauptverfasser: TAN, Chav-Hoon, XIN HE, JUN YANG, ONE, Wei-Yi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 456
container_issue 4
container_start_page 448
container_title Experimental brain research
container_volume 170
creator TAN, Chav-Hoon
XIN HE
JUN YANG
ONE, Wei-Yi
description Potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function has been proposed as being useful in the treatment of depression, but thus far, little is known about the possible changes in AMPA receptor expression in the brain, after antidepressant treatment. The present study was carried out to study the expression of AMPA receptor subunits in different brain regions of mice that had been chronically injected with maprotiline. The latter is a modified tricyclic antidepressant that functions as a noradrenaline uptake inhibitor. Daily intraperitoneal injection with 10 mg/kg maprotiline for 30 days resulted in significantly increased GluR1 and GluR2/3 subunit expression in the nucleus accumbens and dorsal striatum as detected by immunohistochemistry; and significantly increased GluR1 and GluR2/3 expression in the hippocampus, as demonstrated by Western blot analysis. No change, or a decrease in GluR2 expression was detected in all the brain regions by both immunohistochemistry and Western blots. The increase in GluR1 and GluR2/3, but no increase in GluR2 subunits suggests that there could be an increase in calcium permeability of AMPA receptors in limbic/striatal brain regions after maprotiline treatment. This could lead to increased synaptic activity or plasticity in the hippocampus and striatum, and may underlie the therapeutic effect of maprotline, and possibly, other antidepressant drugs.
doi_str_mv 10.1007/s00221-005-0228-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67838961</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67838961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-706465646b0a63f86aa9f665e35679f70b09a2de4c9036bc10fac900b611698e3</originalsourceid><addsrcrecordid>eNqFkc-O0zAQxi0EYsvCA3BBFhLcAmM7sRMuqKr4Jy2CA5ytiTtpvSROsR0tvBMPibuttBIXDpa_sX_zaeyPsacCXgkA8zoBSCkqgKYqoq3kPbYStZKVEKDvsxWAqKu6Fd0Fe5TS9bFUBh6yC6GVBKibFfuz2WPYUeI-8PXnr2ueln4JPnP6dYiUkp_D8SrviU_zkoj3EUuNQ6bI3T7OwTueI2GeKGR-4_P-FsaQ_ZZuLYrkEx7inP3oA_E3HHkRP3hP-YYo8DBH3EYKFHfFDMOW78Yl44T5dDIsweUyyNvH7MGAY6In5_2SfX__7tvmY3X15cOnzfqqcqo1uTKga92U1QNqNbQasRu0bkg12nSDgR46lFuqXQdK907AgEVCr4XQXUvqkr08-Zahfy6Usp18cjSOGKh8gtWmVW2nxX9BWSZRUJsCPv8HvJ6XGMojrBSNqKWsoUDiBLk4pxRpsIfoJ4y_rQB7DNyeArclcHsM3MrS8-xsvPQTbe86zgkX4MUZwORwHCIG59MdZ4xQsu3UXzg2tP4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215142240</pqid></control><display><type>article</type><title>Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline : a link between noradrenergic and glutamatergic function?</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>TAN, Chav-Hoon ; XIN HE ; JUN YANG ; ONE, Wei-Yi</creator><creatorcontrib>TAN, Chav-Hoon ; XIN HE ; JUN YANG ; ONE, Wei-Yi</creatorcontrib><description>Potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function has been proposed as being useful in the treatment of depression, but thus far, little is known about the possible changes in AMPA receptor expression in the brain, after antidepressant treatment. The present study was carried out to study the expression of AMPA receptor subunits in different brain regions of mice that had been chronically injected with maprotiline. The latter is a modified tricyclic antidepressant that functions as a noradrenaline uptake inhibitor. Daily intraperitoneal injection with 10 mg/kg maprotiline for 30 days resulted in significantly increased GluR1 and GluR2/3 subunit expression in the nucleus accumbens and dorsal striatum as detected by immunohistochemistry; and significantly increased GluR1 and GluR2/3 expression in the hippocampus, as demonstrated by Western blot analysis. No change, or a decrease in GluR2 expression was detected in all the brain regions by both immunohistochemistry and Western blots. The increase in GluR1 and GluR2/3, but no increase in GluR2 subunits suggests that there could be an increase in calcium permeability of AMPA receptors in limbic/striatal brain regions after maprotiline treatment. This could lead to increased synaptic activity or plasticity in the hippocampus and striatum, and may underlie the therapeutic effect of maprotline, and possibly, other antidepressant drugs.</description><identifier>ISSN: 0014-4819</identifier><identifier>EISSN: 1432-1106</identifier><identifier>DOI: 10.1007/s00221-005-0228-2</identifier><identifier>PMID: 16320045</identifier><identifier>CODEN: EXBRAP</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Acids ; Animals ; Antidepressants ; Antidepressive Agents - pharmacology ; Biochemistry and metabolism ; Biological and medical sciences ; Brain ; Brain - anatomy &amp; histology ; Brain - drug effects ; Central nervous system ; Drugs ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation - drug effects ; Glutamic Acid - physiology ; Immunohistochemistry ; Maprotiline - pharmacology ; Mice ; Motor control and motor pathways. Reflexes. Control centers of vegetative functions. Vestibular system and equilibration ; Norepinephrine - physiology ; Protein Subunits - metabolism ; Receptors, AMPA - metabolism ; Time Factors ; Vertebrates: nervous system and sense organs</subject><ispartof>Experimental brain research, 2006-04, Vol.170 (4), p.448-456</ispartof><rights>2006 INIST-CNRS</rights><rights>Springer-Verlag 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-706465646b0a63f86aa9f665e35679f70b09a2de4c9036bc10fac900b611698e3</citedby><cites>FETCH-LOGICAL-c387t-706465646b0a63f86aa9f665e35679f70b09a2de4c9036bc10fac900b611698e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17713289$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16320045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TAN, Chav-Hoon</creatorcontrib><creatorcontrib>XIN HE</creatorcontrib><creatorcontrib>JUN YANG</creatorcontrib><creatorcontrib>ONE, Wei-Yi</creatorcontrib><title>Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline : a link between noradrenergic and glutamatergic function?</title><title>Experimental brain research</title><addtitle>Exp Brain Res</addtitle><description>Potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function has been proposed as being useful in the treatment of depression, but thus far, little is known about the possible changes in AMPA receptor expression in the brain, after antidepressant treatment. The present study was carried out to study the expression of AMPA receptor subunits in different brain regions of mice that had been chronically injected with maprotiline. The latter is a modified tricyclic antidepressant that functions as a noradrenaline uptake inhibitor. Daily intraperitoneal injection with 10 mg/kg maprotiline for 30 days resulted in significantly increased GluR1 and GluR2/3 subunit expression in the nucleus accumbens and dorsal striatum as detected by immunohistochemistry; and significantly increased GluR1 and GluR2/3 expression in the hippocampus, as demonstrated by Western blot analysis. No change, or a decrease in GluR2 expression was detected in all the brain regions by both immunohistochemistry and Western blots. The increase in GluR1 and GluR2/3, but no increase in GluR2 subunits suggests that there could be an increase in calcium permeability of AMPA receptors in limbic/striatal brain regions after maprotiline treatment. This could lead to increased synaptic activity or plasticity in the hippocampus and striatum, and may underlie the therapeutic effect of maprotline, and possibly, other antidepressant drugs.</description><subject>Acids</subject><subject>Animals</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - pharmacology</subject><subject>Biochemistry and metabolism</subject><subject>Biological and medical sciences</subject><subject>Brain</subject><subject>Brain - anatomy &amp; histology</subject><subject>Brain - drug effects</subject><subject>Central nervous system</subject><subject>Drugs</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Glutamic Acid - physiology</subject><subject>Immunohistochemistry</subject><subject>Maprotiline - pharmacology</subject><subject>Mice</subject><subject>Motor control and motor pathways. Reflexes. Control centers of vegetative functions. Vestibular system and equilibration</subject><subject>Norepinephrine - physiology</subject><subject>Protein Subunits - metabolism</subject><subject>Receptors, AMPA - metabolism</subject><subject>Time Factors</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0014-4819</issn><issn>1432-1106</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkc-O0zAQxi0EYsvCA3BBFhLcAmM7sRMuqKr4Jy2CA5ytiTtpvSROsR0tvBMPibuttBIXDpa_sX_zaeyPsacCXgkA8zoBSCkqgKYqoq3kPbYStZKVEKDvsxWAqKu6Fd0Fe5TS9bFUBh6yC6GVBKibFfuz2WPYUeI-8PXnr2ueln4JPnP6dYiUkp_D8SrviU_zkoj3EUuNQ6bI3T7OwTueI2GeKGR-4_P-FsaQ_ZZuLYrkEx7inP3oA_E3HHkRP3hP-YYo8DBH3EYKFHfFDMOW78Yl44T5dDIsweUyyNvH7MGAY6In5_2SfX__7tvmY3X15cOnzfqqcqo1uTKga92U1QNqNbQasRu0bkg12nSDgR46lFuqXQdK907AgEVCr4XQXUvqkr08-Zahfy6Usp18cjSOGKh8gtWmVW2nxX9BWSZRUJsCPv8HvJ6XGMojrBSNqKWsoUDiBLk4pxRpsIfoJ4y_rQB7DNyeArclcHsM3MrS8-xsvPQTbe86zgkX4MUZwORwHCIG59MdZ4xQsu3UXzg2tP4</recordid><startdate>20060401</startdate><enddate>20060401</enddate><creator>TAN, Chav-Hoon</creator><creator>XIN HE</creator><creator>JUN YANG</creator><creator>ONE, Wei-Yi</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88J</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2R</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20060401</creationdate><title>Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline : a link between noradrenergic and glutamatergic function?</title><author>TAN, Chav-Hoon ; XIN HE ; JUN YANG ; ONE, Wei-Yi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-706465646b0a63f86aa9f665e35679f70b09a2de4c9036bc10fac900b611698e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acids</topic><topic>Animals</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - pharmacology</topic><topic>Biochemistry and metabolism</topic><topic>Biological and medical sciences</topic><topic>Brain</topic><topic>Brain - anatomy &amp; histology</topic><topic>Brain - drug effects</topic><topic>Central nervous system</topic><topic>Drugs</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Glutamic Acid - physiology</topic><topic>Immunohistochemistry</topic><topic>Maprotiline - pharmacology</topic><topic>Mice</topic><topic>Motor control and motor pathways. Reflexes. Control centers of vegetative functions. Vestibular system and equilibration</topic><topic>Norepinephrine - physiology</topic><topic>Protein Subunits - metabolism</topic><topic>Receptors, AMPA - metabolism</topic><topic>Time Factors</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TAN, Chav-Hoon</creatorcontrib><creatorcontrib>XIN HE</creatorcontrib><creatorcontrib>JUN YANG</creatorcontrib><creatorcontrib>ONE, Wei-Yi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Social Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TAN, Chav-Hoon</au><au>XIN HE</au><au>JUN YANG</au><au>ONE, Wei-Yi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline : a link between noradrenergic and glutamatergic function?</atitle><jtitle>Experimental brain research</jtitle><addtitle>Exp Brain Res</addtitle><date>2006-04-01</date><risdate>2006</risdate><volume>170</volume><issue>4</issue><spage>448</spage><epage>456</epage><pages>448-456</pages><issn>0014-4819</issn><eissn>1432-1106</eissn><coden>EXBRAP</coden><abstract>Potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function has been proposed as being useful in the treatment of depression, but thus far, little is known about the possible changes in AMPA receptor expression in the brain, after antidepressant treatment. The present study was carried out to study the expression of AMPA receptor subunits in different brain regions of mice that had been chronically injected with maprotiline. The latter is a modified tricyclic antidepressant that functions as a noradrenaline uptake inhibitor. Daily intraperitoneal injection with 10 mg/kg maprotiline for 30 days resulted in significantly increased GluR1 and GluR2/3 subunit expression in the nucleus accumbens and dorsal striatum as detected by immunohistochemistry; and significantly increased GluR1 and GluR2/3 expression in the hippocampus, as demonstrated by Western blot analysis. No change, or a decrease in GluR2 expression was detected in all the brain regions by both immunohistochemistry and Western blots. The increase in GluR1 and GluR2/3, but no increase in GluR2 subunits suggests that there could be an increase in calcium permeability of AMPA receptors in limbic/striatal brain regions after maprotiline treatment. This could lead to increased synaptic activity or plasticity in the hippocampus and striatum, and may underlie the therapeutic effect of maprotline, and possibly, other antidepressant drugs.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>16320045</pmid><doi>10.1007/s00221-005-0228-2</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4819
ispartof Experimental brain research, 2006-04, Vol.170 (4), p.448-456
issn 0014-4819
1432-1106
language eng
recordid cdi_proquest_miscellaneous_67838961
source MEDLINE; SpringerLink Journals
subjects Acids
Animals
Antidepressants
Antidepressive Agents - pharmacology
Biochemistry and metabolism
Biological and medical sciences
Brain
Brain - anatomy & histology
Brain - drug effects
Central nervous system
Drugs
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation - drug effects
Glutamic Acid - physiology
Immunohistochemistry
Maprotiline - pharmacology
Mice
Motor control and motor pathways. Reflexes. Control centers of vegetative functions. Vestibular system and equilibration
Norepinephrine - physiology
Protein Subunits - metabolism
Receptors, AMPA - metabolism
Time Factors
Vertebrates: nervous system and sense organs
title Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline : a link between noradrenergic and glutamatergic function?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T05%3A17%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20AMPA%20subunit%20expression%20in%20the%20mouse%20brain%20after%20chronic%20treatment%20with%20the%20antidepressant%20maprotiline%20:%20a%20link%20between%20noradrenergic%20and%20glutamatergic%20function?&rft.jtitle=Experimental%20brain%20research&rft.au=TAN,%20Chav-Hoon&rft.date=2006-04-01&rft.volume=170&rft.issue=4&rft.spage=448&rft.epage=456&rft.pages=448-456&rft.issn=0014-4819&rft.eissn=1432-1106&rft.coden=EXBRAP&rft_id=info:doi/10.1007/s00221-005-0228-2&rft_dat=%3Cproquest_cross%3E67838961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215142240&rft_id=info:pmid/16320045&rfr_iscdi=true